LT3347002T - Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje - Google Patents
Alzheimerio ligos gydymas tam tikroje pacientų populiacijojeInfo
- Publication number
- LT3347002T LT3347002T LTEPPCT/US2016/051091T LT16051091T LT3347002T LT 3347002 T LT3347002 T LT 3347002T LT 16051091 T LT16051091 T LT 16051091T LT 3347002 T LT3347002 T LT 3347002T
- Authority
- LT
- Lithuania
- Prior art keywords
- alzheimer
- disease
- treatment
- particular patient
- patient population
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562216404P | 2015-09-10 | 2015-09-10 | |
| US201662290287P | 2016-02-02 | 2016-02-02 | |
| US201662302027P | 2016-03-01 | 2016-03-01 | |
| US201662365809P | 2016-07-22 | 2016-07-22 | |
| PCT/US2016/051091 WO2017044840A1 (en) | 2015-09-10 | 2016-09-09 | Methods of treating neurodegenerative disorders in a particular patient population |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3347002T true LT3347002T (lt) | 2023-09-11 |
Family
ID=58240195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2016/051091T LT3347002T (lt) | 2015-09-10 | 2016-09-09 | Alzheimerio ligos gydymas tam tikroje pacientų populiacijoje |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US11191742B2 (lt) |
| EP (2) | EP3347002B1 (lt) |
| JP (3) | JP6789579B2 (lt) |
| KR (2) | KR102412997B1 (lt) |
| CN (3) | CN108289870A (lt) |
| AU (1) | AU2016319107B2 (lt) |
| CA (1) | CA2997376C (lt) |
| DK (1) | DK3347002T3 (lt) |
| ES (1) | ES2952727T3 (lt) |
| FI (1) | FI3347002T3 (lt) |
| HK (1) | HK1257874A1 (lt) |
| HR (1) | HRP20230809T1 (lt) |
| HU (1) | HUE062511T2 (lt) |
| LT (1) | LT3347002T (lt) |
| MD (1) | MD3347002T2 (lt) |
| MX (2) | MX2018003023A (lt) |
| PL (1) | PL3347002T3 (lt) |
| PT (1) | PT3347002T (lt) |
| RS (1) | RS64481B1 (lt) |
| SI (1) | SI3347002T1 (lt) |
| WO (1) | WO2017044840A1 (lt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2960625T3 (es) | 2014-03-21 | 2024-03-05 | Alzheon Inc | Compuestos para uso en el tratamiento de la enfermedad de Alzheimer en pacientes de ApoE4+/+ |
| US11191742B2 (en) * | 2015-09-10 | 2021-12-07 | Alzheon, Inc. | Methods of treating neurodegenerative disorders in a particular population |
| CN108623501B (zh) | 2017-03-21 | 2022-04-19 | 润佳（苏州）医药科技有限公司 | 同位素富集的3-氨基-1-丙磺酸衍生物及其用途 |
| CN110003058B (zh) | 2018-01-04 | 2022-01-25 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-3,3-二氘-1-丙磺酸晶型、制备方法及用途 |
| SG11202100767XA (en) * | 2018-08-01 | 2021-02-25 | Alzheon Inc | Methods for treating neurodegenerative disorders |
| HRP20231576T1 (hr) * | 2018-08-01 | 2024-03-15 | Alzheon, Inc. | Derivati sulfopropanske kiseline za liječenje neurodegenerativnih poremećaja |
| CN111170901A (zh) * | 2018-11-13 | 2020-05-19 | 润佳（苏州）医药科技有限公司 | 3-((l-缬氨酰基)氨基)-1-丙磺酸晶型、制备方法及其用途 |
| KR20220024434A (ko) | 2019-06-17 | 2022-03-03 | 알제온, 인크. | 신경퇴행성 장애를 치료하는 방법 |
| WO2023107658A1 (en) * | 2021-12-09 | 2023-06-15 | Alzheon, Inc. | Alz-801 for use in treating alzheimer's disease |
| WO2023150381A1 (en) * | 2022-02-07 | 2023-08-10 | Alzheon, Inc. | Alz-801 for use in treating a covid-19 associated neurological symptom |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698155A (en) | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
| NZ257215A (en) | 1992-10-13 | 1996-12-20 | Univ Duke | Diagnosis or prognosis of alzheimers using the presence of apolipoprotein e type 4 as an indicator and apolipoprotein e isoform specific antibodies |
| US20050031651A1 (en) | 2002-12-24 | 2005-02-10 | Francine Gervais | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| US20050142191A1 (en) | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20060079578A1 (en) | 2003-06-23 | 2006-04-13 | Julie Laurin | Pharmaceutical formulations of amyloid inhibiting compounds |
| SG145784A1 (en) | 2003-08-11 | 2008-09-29 | California Inst Of Techn | Microfluidic large scale integration |
| KR20070120190A (ko) * | 2005-04-12 | 2007-12-21 | 뉴로켐 (인터내셔널) 리미티드 | 아밀로이드 억제 화합물의 제약 제제 |
| DK3851447T3 (da) | 2006-10-12 | 2023-12-04 | Bellus Health Inc | Fremgangsmåder, forbindelser, sammensætninger og vehikler til administration af 3-amino-1-propansulfonsyre |
| ES2587014T3 (es) | 2006-11-24 | 2016-10-20 | Ac Immune S.A. | Derivados de N-(metil)-piridin-2-amina para el tratamiento de enfermedades asociadas a proteínas amiloides o de tipo amiloide |
| JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
| US20120009125A1 (en) | 2010-07-06 | 2012-01-12 | Lombard Jay L | Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| ES2705027T3 (es) | 2010-08-19 | 2019-03-21 | Buck Institute For Age Res | Métodos de tratamiento del deterioro cognitivo leve (DCL) y trastornos relacionados |
| PT2994160T (pt) * | 2013-05-06 | 2019-08-07 | Baxalta Inc | Tratamento de sub-populações com doença de alzheimer com imunoglobulina g combinada |
| TWI705824B (zh) | 2014-02-08 | 2020-10-01 | 美商建南德克公司 | 治療阿茲海默症之方法 |
| ES2960625T3 (es) * | 2014-03-21 | 2024-03-05 | Alzheon Inc | Compuestos para uso en el tratamiento de la enfermedad de Alzheimer en pacientes de ApoE4+/+ |
| US11191742B2 (en) * | 2015-09-10 | 2021-12-07 | Alzheon, Inc. | Methods of treating neurodegenerative disorders in a particular population |
-
2016
- 2016-09-09 US US15/758,405 patent/US11191742B2/en active Active
- 2016-09-09 JP JP2018512564A patent/JP6789579B2/ja active Active
- 2016-09-09 SI SI201631729T patent/SI3347002T1/sl unknown
- 2016-09-09 FI FIEP16845181.3T patent/FI3347002T3/fi active
- 2016-09-09 AU AU2016319107A patent/AU2016319107B2/en active Active
- 2016-09-09 PT PT168451813T patent/PT3347002T/pt unknown
- 2016-09-09 DK DK16845181.3T patent/DK3347002T3/da active
- 2016-09-09 CN CN201680052760.4A patent/CN108289870A/zh active Pending
- 2016-09-09 CN CN202310582394.5A patent/CN116712423A/zh active Pending
- 2016-09-09 HR HRP20230809TT patent/HRP20230809T1/hr unknown
- 2016-09-09 KR KR1020187009381A patent/KR102412997B1/ko active IP Right Grant
- 2016-09-09 ES ES16845181T patent/ES2952727T3/es active Active
- 2016-09-09 EP EP16845181.3A patent/EP3347002B1/en active Active
- 2016-09-09 CA CA2997376A patent/CA2997376C/en active Active
- 2016-09-09 PL PL16845181.3T patent/PL3347002T3/pl unknown
- 2016-09-09 CN CN202310582365.9A patent/CN116712422A/zh active Pending
- 2016-09-09 KR KR1020227009418A patent/KR102547164B1/ko active IP Right Grant
- 2016-09-09 MD MDE20180700T patent/MD3347002T2/ro unknown
- 2016-09-09 LT LTEPPCT/US2016/051091T patent/LT3347002T/lt unknown
- 2016-09-09 MX MX2018003023A patent/MX2018003023A/es unknown
- 2016-09-09 WO PCT/US2016/051091 patent/WO2017044840A1/en active Application Filing
- 2016-09-09 HU HUE16845181A patent/HUE062511T2/hu unknown
- 2016-09-09 RS RS20230603A patent/RS64481B1/sr unknown
- 2016-09-09 EP EP23176559.5A patent/EP4275750A3/en active Pending
-
2018
- 2018-03-09 MX MX2022003128A patent/MX2022003128A/es unknown
-
2019
- 2019-01-07 HK HK19100235.4A patent/HK1257874A1/zh unknown
-
2020
- 2020-09-28 JP JP2020161995A patent/JP7128536B2/ja active Active
-
2021
- 2021-09-17 US US17/477,886 patent/US20220096406A1/en not_active Abandoned
-
2022
- 2022-08-12 JP JP2022128786A patent/JP2022145949A/ja active Pending
-
2023
- 2023-09-06 US US18/462,238 patent/US20230414541A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3347002T1 (sl) | Zdravljenje Alzheimerjeve bolezni pri določeni populaciji bolnikov | |
| ZA201605341B (en) | Methods of treating alzheimer's disease | |
| IL247085B (en) | Methods for treating Alzheimer's disease | |
| RS64744B1 (sr) | Jedinjenja za upotrebu u lečenju alchajmerove bolesti kod pacijenata sa apoe4+/+ | |
| EP3347486A4 (en) | REDUCTION OF ER-MAM-LOCALIZED APP-C99 AND METHOD FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| HK1243709A1 (zh) | 可用於治療阿爾茨海默氏病的四氫呋喃稠合的氨基氫噻嗪衍生物 | |
| EP3137097C0 (en) | TREATMENT AND PREVENTION OF ALZHEIMER | |
| PL3413870T3 (pl) | Igmezyna do zastosowania do leczenia choroby alzheimera | |
| PL3137093T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| PT3137094T (pt) | Tratamento e prevenção da doença de alzheimer (da) | |
| HK1257598A1 (zh) | 改善心臟病變的藥物及其用途 | |
| IL260009B (en) | Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | |
| GB201511453D0 (en) | Treatment of alzheimer's disease | |
| HK1245081A1 (zh) | 用於治療阿爾茨海默病的方法 | |
| AU2017902309A0 (en) | Treatment of alzheimer's disease | |
| AU2017902307A0 (en) | Treatment of alzheimer's disease | |
| GB201518052D0 (en) | Parkinson's disease treatment | |
| GB201504144D0 (en) | Treatment of Parkinson's disease |